Evidence map›Paper›PMID 41896245›Full record

ArticleNature communications2026

Energetic diversity in retinal ganglion cells is modulated by neuronal activity and correlates with resilience to degeneration.

Zelun Wang, Christopher Zhao, Shelly Xu, Minglei Zhao, Sean McCracken, Rajendra S Apte, Philip R Williams

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Zelun WangJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-3768-6934
Christopher ZhaoJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Shelly XuJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Minglei ZhaoJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Sean McCrackenJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Rajendra S ApteJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA. apte@wustl.edu.ORCID http://orcid.org/0000-0003-2281-2336
Philip R WilliamsJohn F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA. prwillia@wustl.edu.ORCID http://orcid.org/0000-0003-4813-8925

Funding

WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Steven Bassnett · 1985 to 2026
$18.4M
Vulnerable and Resilient Cells in Retinal DegenerationR01EY012543 · NEI · WASHINGTON UNIVERSITY · PI SHIMING CHEN, Philip Raymond Williams · 2000 to 2026
$12.2M
Research Training Program in the Vision SciencesT32EY013360 · NEI · WASHINGTON UNIVERSITY · PI SHIMING CHEN, Daniel Kerschensteiner · 2000 to 2026
$5.6M
Activity-related mechanisms of selective retinal ganglion cell resilience and axon regenerationR01EY036111 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Nicholas Minh Abell Tran · 2024 to 2026
$2.2M
Identifying and leveraging strategies of inherently resilient retinal neurons to treat degenerationR01EY032908 · NEI · WASHINGTON UNIVERSITY · PI Philip Raymond Williams · 2022 to 2026
$1.9M
Kinase regulators of retinal ganglion cell survival and axon regenerationR01EY035684 · NEI · BOSTON CHILDREN'S HOSPITAL · PI ZHIGANG HE, Philip Raymond Williams · 2024 to 2026
$1.9M
BrightFocus Foundation (BrightFocus) National Glaucoma AwardNEI NIH HHS P30 EY002687NEI NIH HHS R01 EY012543NEI NIH HHS R01 EY032908NEI NIH HHS R01 EY035684NEI NIH HHS R01 EY036111NEI NIH HHS T32 EY013360Novartis | Alcon | Alcon Research Institute (ARI) Young Investigator AwardResearch to Prevent Blindness (RPB) Unrestricted grant to Department of OphthalmologyResearch to Prevent Blindness (RPB) Young Investigator Award
6 · The paper itself

Abstract

Neuronal function requires high energy expenditure that is likely customized to meet specific signaling demands. However, little is known about diversity of metabolic homeostasis among divergently-functioning types of neurons. To this end, we examined retinal ganglion cells (RGCs), a population of closely related, yet electrophysiologically distinct excitatory projection neurons. Using in vivo 2-photon imaging to measure ATP with single cell resolution, we identified differential homeostatic energy maintenance in the RGC population that correspond to distinct RGC types. In the presence of circuit activity, the most active RGC type (Alpha RGCs), had lower homeostatic ATP levels than other types and exhibited the greatest magnitude of ATP decline when ATP synthesis was inhibited. By simultaneously manipulating circuit activity and mitochondrial function, we found that while oxidative phosphorylation was required to meet ATP demands during circuit activity, it was expendable to maintain resting ATP levels. We also examined ATP signatures associated with survival and injury response after axotomy and report a correlation between low homeostatic ATP and increased survival. In addition, we observed transient ATP increases in RGCs following axon injury. Together, these findings identify diversity of energy handling capabilities of dynamically active neurons with implications for neuronal resilience.

Indexed as

Adenosine TriphosphateEnergy MetabolismRetinal Ganglion CellsAnimalsAxonsAxotomyCell SurvivalHomeostasisMaleMiceMice, Inbred C57BLMitochondriaNeuronsOxidative PhosphorylationAdenosine Triphosphate

Identifiers

PMID41896245
PMCPMC13194979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.